* B·R·A·H·M·S PCT sensitive KRYPTOR, B·R·A·H·M·S PCT LIA, VIDAS® B·R·A·H·M·S PCT. Please see US package inserts for details.

This website has been designed to provide information about the biomarker procalcitonin (PCT) and its utilisation in clinical practice.

Procalcitonin (PCT) is an innovative and highly specific marker for the diagnosis of clinically relevant bacterial infections and sepsis. Procalcitonin (PCT) supports early diagnosis and clinical decision making which could direct an effective therapy at the right time and save unnecessary spending for critically ill patients.

If you are looking for a PCT assay: B·R·A·H·M·S Aktiengesellschaft offers several assays for determination of procalcitonin* in human serum and plasma:

• For diagnosis of invasive bacterial infection/sepsis:
  B·R·A·H·M·S PCT-Q (rapid assay)
  B·R·A·H·M·S PCT LIA (manual assay)
  LIAISON^®B·R·A·H·M·S PCT (automated assay)
  
  
• For diagnosis of LRTI and invasive bacterial infections/sepsis:
  B·R·A·H·M·S PCT KRYPTOR (automated assay)
  ELECSYS^® B·R·A·H·M·S PCT (automated assay)
  VIDAS^® B·R·A·H·M·S PCT* (automated assay)
  B·R·A·H·M·S PCT sensitive LIA (manual assay)

For further information please contact our customer service by email or contact form.
*VIDAS B·R·A·H·M·S PCT is exclusively marketed by bioMerieux.

This website is outside the U.S. Products and/or uses listed may not be available to our customers in the U.S.
Please visit our US Website for detailed information on product availability in the U.S.